Skip to Content
Merck
CN
All Photos(1)

Documents

Safety Information

SAB4200143

Sigma-Aldrich

Anti-ADAR2 antibody, Mouse monoclonal

clone ADAR2-15, purified from hybridoma cell culture

Sign Into View Organizational & Contract Pricing

Synonym(s):
Anti-ADARB1, Anti-Adenosine Deaminase, RNA-specific B1, Anti-DRABA2, Anti-DRADA2, Anti-RED1, Anti-RNA Editase 1, Anti-RNA-editing enzyme 1
MDL number:
UNSPSC Code:
12352203
NACRES:
NA.41

biological source

mouse

conjugate

unconjugated

antibody form

purified from hybridoma cell culture

antibody product type

primary antibodies

clone

ADAR2-15, monoclonal

form

buffered aqueous solution

mol wt

antigen ~130 kDa

species reactivity

human

technique(s)

western blot: 1:250-1:500 using HEK-293T cells overexpressing ADAR2 (a working dilution)

isotype

IgG

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... ADAR2(104)

Looking for similar products? Visit Product Comparison Guide

General description

Adenosine deaminase acting on RNA type 2 (ADAR2), also known as adenosine deaminase, RNA specific B1 (ADARB1), is encoded by the gene mapped to human chromosome 21q22.3. ADARB1 is characterized with two double-stranded RNA-binding domains and a deaminase domain involved in editing action.
Monoclonal Anti-ADAR2 (mouse IgG2a isotype) is derived from the hybridoma ADAR2-15 produced by the fusion of mouse myeloma cells and splenocytes from BALB/c mice immunized with a synthetic peptide corresponding to a fragment of human ADAR2, conjugated to KLH. Adenosine deaminase acting on RNA type 2 is expressed mainly in nucleus.

Specificity

Monoclonal Anti-ADAR2 recognizes human ADAR2

Application

Monoclonal Anti-ADAR2 antibody produced in mouse may be used in several immunochemical techniques including immunoblotting.

Biochem/physiol Actions

Adenosine deaminase acting on RNA type 2 (ADAR2) enzyme plays a vital role in editing pre-mRNA of glutamate receptor B subunit. Combined effect of ADAR2 and HTR2C (5-hydroxytryptamine receptor 2C) variants contribute to the suicide attempt (SA) vulnerability in psychiatric patients. ADAR2 is a candidate gene for neurological diseases, such as bipolar affective disorder and epilepsy. Decrease in the activity of ADAR2 enzyme results in α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor-mediated death of motor neurons in mice. ADAR2 enzyme is expressed consistently in carcinomas and sarcomas and it is upregulated in lymphomas and seminomas when compared to normal tissues.

Physical form

Solution in 0.01M phosphate buffered saline pH 7.4, containing 15 mM sodium azide and horse immunoglobulins

Storage and Stability

Store at −20 °C. For continuous use, store at 2–8 °C for up to one month. For extended storage, freeze at −20 °C in working aliquots. Repeated freezing and thawing, or storage in “frost-free” freezers, is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilution samples should be discarded if not used within 12 hours.

Disclaimer

Unless otherwise stated in our catalog, our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

新产品

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

SUMO-1 modification alters ADAR1 editing activity
Desterro JMP
Molecular Biology of the Cell, 16(11), 5115-5126 (2005)
Sequence analysis of ADARB1 gene in patients with familial bipolar disorder.
Amore M
Journal of Affective Disorders, 81, 79-85 (2004)
Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets.
Flanagan JM
Molecular Cancer Therapeutics, 8, 249-260 (2009)
Cloning of a human RNA editing deaminase (ADARB1) of glutamate receptors that maps to chromosome 21q22.3.
Mittaz L
Genomics, 41, 210-217 (1997)
Induced Loss of ADAR2 Engenders Slow Death of Motor Neurons from Q/R Site-Unedited GluR2
J Neurosci
The Journal of Neuroscience, 30, 11917-11925 (2010)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service